Introduction
Welcome to a new annual series for Seminars in Cardiothoracic and Vascular Anesthesia. This is the inaugural article. Each year the themes may change, but the goal of the series will remain the same: To share remarkable echocardiographic discoveries that will likely affect anesthetic practice, ongoing and upcoming research, or the vision of perioperative echocardiography as a whole. What a year it has been. After much debate and review of the many significant 2017 echocardiographic articles, a few predominant themes surfaced. First, advancements in 3-dimensional (3D) technology have had significant impact on general valve diagnosis as well as intraprocedural success and perioperative management of minimally invasive mitral valve procedures. Additionally, this review distinctly focuses on the advancements of perioperative echocardiographic techniques and research, and use in the intensive care unit.
Mitral Valve Imaging

Advancements in Use of 3D Imaging for Mitral Valve Evaluation
Advances in mitral valve imaging have been propelled by advancements in 3D imaging capabilities. In 42 cardiac surgery patients, 22 with functional mitral regurgitation and 20 with degenerative mitral valve disease, Cobey et al 1 utilized 3D echo to assess the temporal changes of the vena contracta area during systole. The 2 disease phenotypes displayed different temporal patterns. Functional mitral regurgitation showed a biphasic temporal pattern, whereas degenerative mitral valve disease was monophasic. Temporal analysis of the vena contracta area may in the future facilitate grading mitral regurgitation severity and differentiating valve pathophysiology. This finding may prove significant in answering the age-old question, "Mitral regurgitation-is it degenerative or function?" Similarly, Bouma et al 2 utilized 3D analysis in ischemic mitral regurgitation to predict treatment outcome. In 50 patients referred for valve repair for ischemic mitral regurgitation with undersized annuloplasty rings, preoperative annular geometry was similar throughout the population, but 3D assessment also identified preoperative mitral leaflet tethering by mitral annular area, mitral valve tethering area, and mitral valve tethering volume. Those patients with mitral valve tethering experienced a significantly higher rate of recurrent mitral regurgitation after repair. These relatively simple 3D indices, therefore, may offer future utility for management for ischemic mitral regurgitation. of valve in valve, valve in ring, and native replacement techniques. 3 This new procedural horizon has further established the importance and utility of perioperative echocardiographic evaluation, with particular attention on intraprocedural applicability.
While the debate over computed tomography (CT) with or without transesophageal echocardiography (TEE) sizing for transcatheter aortic valve replacement continues, a new debate is developing over the utility of TEE for mitral valve annuls measurements during minimally invasive mitral valve replacements. In 41 patients under consideration for transcatheter mitral valve implementation, Mak et al 4 demonstrated that 3D-TEE and CT were nearly equivalent. Mean mitral annular area by 3D-TEE and CT were 11.3 ± 2.7 versus 11.4 ± 3.0 (P = .67), with mean septal-to-lateral and intertrigone distances by 3D-TEE and CT 33.2 ± 4.7 versus 32.5 ± 4.4 (P = .24) and 31.7 ± 3.5 versus 32.6 ± 3.6 (P = .06), respectively. Time will tell, but currently, intraprocedural TEE is a critical part of procedural guidance, but this study also suggests that TEE can be useful for valve sizing either by de novo measurements or to clarify valve sizing during the procedure.
Additionally, with mitral valve in valve implantation, Hanson et al studied echocardiographic indices associated with postdeployment left ventricular outflow tract (LVOT) obstruction. 5 They defined the S-Sept measurement (the distance between mitral valve bioprosthetic struts and septum) and found it to be highly associated with increasing LVOT gradients postdeployment. They identified a potential cutoff of <7.5 mm on predeployment evaluation to raise concern for increasing LVOT gradients postdeployment. This measurement needs more evaluation but may become an invaluable tool to aid in future patient selection. These 2 studies add to the body of literature supporting TEE's critical and evolving role in minimally invasive mitral valve replacement procedures.
Advances in Perioperative Echocardiographic Evaluation
The prevalence of the use of echocardiography continues to rise throughout the modern medical world, both in the inpatient and outpatient settings. It is a noninvasive, portable, and reliable modality that provides an important diagnostic tool that oftentimes alters and guides treatment.
But is it overused? Papolos et al 6 aimed to answer this question, as well as evaluate national trends, practice patterns, and outcomes associated with inpatient echo use in the Nationwide Inpatient Sample between 2001 and 2011. During this time period, use of echocardiography grew at an average annual rate of 3.41%, while hospitalizations in which echocardiography was coded as the primary diagnostic procedure had declining rates of hospital length of stay and mortality. During 2010, multivariate logistic regression analysis found that the use of echocardiography was associated with significantly lower odds of all-cause in-hospital mortality in patients with admission diagnoses of dysrhythmias, acute cerebrovascular disease, congestive heart failure, sepsis, altered mental status, but not coronary artery disease, valvular heart disease, or nonspecific chest pain. Based on the 2008 appropriate use criteria for echocardiography, the nationally representative sample by Papolos et al also found that despite echocardiography's growing use, it is in fact underused on a national level during critical cardiovascular hospitalizations. The authors postulate this underuse of echocardiography could be partially explained by physician stewardship or by cost bundling agreements between insurance providers and hospitals.
Another prominent study in the last year aimed to evaluate the expanded inpatient use of echocardiography to determine elevated left ventricular (LV) filling pressure in patients admitted with concern for heart failure. LV filling pressures are instrumental in the diagnosis of heart failure and aid in evaluating response to treatment. For heart failure patients in the past, cardiac catheterization has been the most validated tool to measure filling pressures, as symptoms, clinical exam, laboratory studies, and imaging can paint a confusing picture in terms of delineating a heart failure diagnosis and etiology. Recent American Society of Echocardiography clinical practice guidelines on how to use echocardiography to estimate LV filling pressures have not been validated against invasively measured filling pressures. In a multicenter study including 450 patients, Andersen et al 7 performed an echocardiographic exam to estimate LV filling pressures in patients also referred for cardiac catheterization. An algorithmic approach was used to estimate LV filling pressures based on echo data (left atrial volume index, flow velocities, tissue Doppler velocities). The authors found that echocardiography can feasibly identify patients with elevated LV filling pressure with good accuracy (87%), and especially when combined with clinical data (physical exam, chest X-ray, laboratory data). This study highlighted the important role of echocardiography in evaluating LV filling pressures without invasive measures and in those with clinically complex clinical evaluation. For those patients with multiple risk factors and concerning preoperative presentation, this evaluation may provide further information to the cardiac anesthesiologist taking care of high-risk noncardiac surgery patients.
There is also believed to be an increasing role for the use of screening echocardiography in an outpatient setting. Retrospective and historical data have shown that degenerative valvular heart disease (VHD) increases in prevalence with age, and the anticipated rise in the number of older people in the population will result in an increase in those living with VHD. The OxValve Population Cohort Study was the first population-based prospective analysis evaluating more than 2500 individuals aged >65 years who were screened for undiagnosed VHD using transthoracic echocardiography (TTE) to demonstrate the contemporary clinical and epidemiological characteristics of VHD. 8 Moderate or severe VHD was newly diagnosed in 6.4% of participants, and one third (38.5%) of the study population had multiple valve lesions identified. Participants with newly diagnosed CHD were an average of 2.4 years older and prevalence was found to increase linearly with age. Multiple regression analysis showed that VHD was associated with older age, more deprived socioeconomic status, history of atrial fibrillation, and higher systolic blood pressure. The authors predict a significant rise in the clinical impact and financial burden of clinically significant VHD with the increasing elderly population. The use of TTE on diagnosing previously undetected VHD has allowed us to evaluate the emerging epidemic of VHD and prepare for future implications and investigative research on the pathophysiology, risk factors, outcomes, and treatments.
Advances in the Management of Critically Ill Patients
Cardiac anesthesiologists are increasingly evaluating patients outside of the traditional cardiac anesthesia realm. There has been a significant push in the last year by critical care anesthesiologists to take ownership of ultrasound evaluation in the critical care units with renewed calls to establish certification [9] [10] [11] pathways for intensivists as well as international guidelines 12 in critical care echocardiography (CCE), which utilizes both TEE and TTE. This expansion of echocardiography makes the skill set of not only intensivists but also cardiac anesthesiologists invaluable to patient care in these environments.
Noteworthy studies of this prior year mirror previous echocardiographic studies conducted in the cardiac operating arena. They establish the validity of quantitative methods in the intensive care environment. Mercado et al studied 38 mechanically ventilated critically ill patients. They found that cardiac output monitoring by TTE and pulmonary artery catheter demonstrate high correlation (r = .95, P < .0001), similar levels of precision, and, perhaps most important, high correlation between ΔCO-PAC (cardiac output from pulmonary artery catheter) and ΔCO-TTE (r = .92, P < .0001). 13 In a similar but larger multicenter trial, Vignon et al 14 applied CCE (TTE or TEE) versus PAC with a treatment algorithm to optimize perfusion in septic shock mechanically ventilated patients. The investigators found no difference in clinical outcomes, but CCE provided more accurate hemodynamic assessment and identified multiple unexpected valvular and ventricular abnormalities. These 2 studies build on the TEE studies previously conducted in the cardiac operating room that solidified TEE as a useful monitor of cardiac output using PAC as the gold standard. However, they provide additional utility by showing that the accuracy of TEE for detecting changes in cardiac output was also as good or in the second study better than PAC because it identified other cardiac lesions.
In a similar but different study, 30 mechanically ventilated patients with hypotension, Jozwiak et al 15 studied the variability in LVOT velocity time integral during end expiratory versus end inspiratory occlusion. They found that fluid responders demonstrated a variability of 23 ± 9% versus 8 ± 3% in fluid nonresponders. This suggests that both in the operating room and in the intensive care unit, cardiopulmonary interactions could be protocolized and leveraged to better assess volume status.
The year 2017 was an exciting year for advances in perioperative echocardiography. The speed and breadth of these new studies mirror the expansion of minimally invasive valvular procedures, particularly with regard to the mitral valve. Advanced imaging is driving new concepts to capture the functional anatomy of the mitral valve and how imaging can guide or predict the outcomes from interventions. Ischemic mitral regurgitation and valve in valve procedures present challenging clinical situations that echocardiography is providing useful information to support decision making. Even as studies show us that echocardiography may be underutilized in the hospital patient, the role of echocardiography in the evaluation of patients in the perioperative period continues to expand as we learn more about its utility to define a patient's left ventricular filling pressures, uncover clinically significant valvular disease, and guide complex decision making in the critically ill patient. We look forward to echocardiographic innovation and advancement in 2018.
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